Page 12

Cover Story Cardiac Biomarkers - An Overview

CARDIAC Dr. D. M. Vasudevan, MBBS, MD, (Biochem), FRCPath, Technical Director, AGAPPE.

BIOMARKERS A biomarker is defined as one naturally occurring molecule, gene or characteristic by which a particular pathological process, disease etc. can be identified. Cardiac markers are used in the diagnosis and risk stratification of patients with cardiac diseases, chest pain and suspected acute coronary syndrome (ACS).

A biomarker is defined as one naturally occurring

molecule, gene or characteristic by which a particular pathological process, disease etc. can be identified. Cardiac markers are used in the diagnosis and risk stratification of patients with cardiac diseases, chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Indeed, cardiac troponin is central to the definition of acute myocardial infarction (MI) in the consensus guidelines from the European Society of Cardiology (ESC) and the American College of Cardiology (ACC): These guidelines recommend that cardiac biomarkers should be measured at presentation in patients with suspected MI, and that the only biomarker that is recommended to be used for the diagnosis of acute MI at this time is cardiac troponin due to its superior sensitivity and accuracy. These cardiac markers are shown in Table 1. Please see Table 2, where the markers are tested.

12

TECHAGAPPE

APRIL-JUNE 2018

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Advertisement